Latest News
-
K-Bio shifts focus to clinical data as key trial readouts stack up in second half (News1)2026.07.02
-
“K-Bio has become a ‘new modality leader’…Time to shift to an inbound strategy and strengthen the ecosystem” (The Bio)2026.06.29
-
Korea biotech confronts IPO fixation, pushes flexible capital and global deals (Chosun Biz)2026.06.26
-
[BIO USA] Vice President Lee Seung-kyou urges urgent early-stage PoC fund to counter China's aggressive expansion (The Bio)2026.06.25






